Atterocor is a drug development company focused on the accelerated development of a novel treatment for adrenal cancer,
a rare endocrine cancer.

Learn More

June 12, 2014
Atterocor Announces Data Presentations at ICE/ENDO 2014 Read More >>

December 18, 2013
Atterocor Appoints Leading Experts to Clinical Advisory Board Read More >>